MIA
NVIV

Milestone Investment Advisors’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History

Milestone Investment Advisors’s Portfolio NVIV Stock Details NVIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1
Closed -$2 – 449
2023
Q3 		$2 Buy
+1
New +$1 ﹤0.01% 443
2023
Q2 		– Sell
-1
Closed -$2 – 449
2023
Q1 		$2 Buy
+1
New +$2 ﹤0.01% 444

Other funds holding NVIV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return
CTA
Colonial Trust Advisors Spartanburg, South Carolina $1.29B AUM 19.9% 1-Year Est. Return
ITIM
Indiana Trust & Investment Management Mishawaka, Indiana $366M AUM 33.66% 1-Year Est. Return

Milestone Investment Advisors's NVIV Position: Q4 2023 in Review

Milestone Investment Advisors sold out of InVivo Therapeutics Holdings Corp (NVIV) in Q4 2023, closing a stake of 1 share — an estimated $2 sold.

Milestone Investment Advisors first reported a position in NVIV in Q1 2023 and held it in 2 quarters. The position peaked at $2 in Q3 2023. 14 funds tracked by Wall St. Rank hold NVIV as of Q4 2023.

  • Milestone Investment Advisors reported no remaining InVivo Therapeutics Holdings Corp position as of Q4 2023 after selling out during the quarter.
  • Milestone Investment Advisors sold 1 InVivo Therapeutics Holdings Corp share in Q4 2023, an estimated $2.
  • Milestone Investment Advisors first reported a position in InVivo Therapeutics Holdings Corp in Q1 2023 and held it in 2 quarters.
  • Milestone Investment Advisors's InVivo Therapeutics Holdings Corp position peaked at $2 in Q3 2023.
  • 14 funds tracked by Wall St. Rank held InVivo Therapeutics Holdings Corp as of Q4 2023.

Based on Milestone Investment Advisors's 13F filing for Q4 2023, filed 9 Feb 2024.